Correlation Between IShares Genomics and Invesco PHLX

Can any of the company-specific risk be diversified away by investing in both IShares Genomics and Invesco PHLX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Genomics and Invesco PHLX into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between iShares Genomics Immunology and Invesco PHLX Semiconductor, you can compare the effects of market volatilities on IShares Genomics and Invesco PHLX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Genomics with a short position of Invesco PHLX. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Genomics and Invesco PHLX.

Diversification Opportunities for IShares Genomics and Invesco PHLX

-0.11

Correlation Coefficient

IShares Genomics  Invesco PHLX

Good diversification

The 3 months correlation between IShares and Invesco is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding iShares Genomics Immunology and Invesco PHLX Semiconductor in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invesco PHLX Semicon and IShares Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Genomics Immunology are associated (or correlated) with Invesco PHLX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invesco PHLX Semicon has no effect on the direction of IShares Genomics i.e., IShares Genomics and Invesco PHLX go up and down completely randomly.

Pair Corralation between IShares Genomics and Invesco PHLX

Given the investment horizon of 90 days iShares Genomics Immunology is expected to under-perform the Invesco PHLX. But the etf apears to be less risky and, when comparing its historical volatility, iShares Genomics Immunology is 1.1 times less risky than Invesco PHLX. The etf trades about -0.04 of its potential returns per unit of risk. The Invesco PHLX Semiconductor is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  4,027  in Invesco PHLX Semiconductor on October 24, 2024 and sell it today you would earn a total of  208.00  from holding Invesco PHLX Semiconductor or generate 5.17% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

iShares Genomics Immunology  vs.  Invesco PHLX Semiconductor

iShares Genomics Imm

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days iShares Genomics Immunology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, IShares Genomics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Invesco PHLX Semicon

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Invesco PHLX Semiconductor are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Invesco PHLX is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with IShares Genomics and Invesco PHLX

The main advantage of trading using opposite IShares Genomics and Invesco PHLX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Genomics position performs unexpectedly, Invesco PHLX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco PHLX will offset losses from the drop in Invesco PHLX's long position.

The idea behind iShares Genomics Immunology and Invesco PHLX Semiconductor pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.